about
Blood-Based Proteomic Biomarkers of Alzheimer's Disease PathologySensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's diseaseNeuroimaging of dementia in 2013: what radiologists need to know.Blood-based biomarkers of Alzheimer's disease: challenging but feasibleDeep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.Blood biomarkers for Alzheimer's disease.Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.CohortExplorer: A Generic Application Programming Interface for Entity Attribute Value Database Schemas.FASTKD2 is associated with memory and hippocampal structure in older adults.Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumesAutomated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status.A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease.Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.Combination treatments in Alzheimer's disease: risks and benefits.Challenges in the development of companion diagnostics for neuropsychiatric disorders.Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?Genetics and brain morphology.The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals.Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk populationAre premorbid abnormal personality traits associated with behavioural and psychological symptoms in dementia?No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.Effects of freezer storage time on levels of complement biomarkers.Data Platform for the Research and Prevention of Alzheimer's Disease.No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.Biogerontology in Finland.Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease.Medial temporal lobe atrophy scores translated to clinical practice: editorial comment on 'influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs'.Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
P2860
Q26774743-9464D322-9755-4796-A9F6-786823C4BFF1Q28742333-F999A468-9F60-46CC-81AF-DDAF215A7E59Q30654332-4DB5754D-CD47-4871-AEB0-E70EC76BE996Q33824444-E74EFD00-62B8-4A3B-B9CC-66BF1189A99BQ33833796-814585A8-5871-4AB3-A06A-FC078A9993CBQ34624763-0E42889B-13CF-4FDF-931A-2549AAC0CAD6Q34769550-F30623CE-A3E7-491C-874F-B425BF01CB9CQ34882357-44A14246-6B83-49A8-9E36-27C219067D23Q35593903-814C4D9B-C19C-4B64-9B62-B58F313A1328Q35813149-5DD311D1-EB33-4655-A15B-F6556836C8BFQ35930847-5DE0A0AD-C177-4672-9BF0-44621ECF63F0Q36032418-715087B2-C44F-4A98-B697-11F13C774544Q37054037-F5277C56-D8B4-4B1E-A6C8-DA8ACF8B8F93Q37126328-2056E6AB-208F-4F05-A712-FED7675284D7Q37237863-E37D88B7-B94A-468A-AC05-AFAE3214D212Q37635614-F7D0ED58-967C-4A79-8151-9C83B3D78274Q37737293-D96F8F1E-DC94-4000-83B0-5C089BB49EDAQ37948846-5B233BA5-063A-4AE8-8ECF-D471EB2833BDQ38060638-112BF4BE-C165-47A2-94C6-05C4E55E1395Q38379199-7B689BBF-F27D-479A-BB24-AE0EA9F5ABFBQ38732582-17E048F8-7860-4EA3-8757-F524AE3E36B7Q38741096-445C687B-266E-43B3-B6DC-EED48B949370Q39928268-B3069AB9-6ECB-4042-ADA0-621A645B9047Q46631793-D112BCC0-72F8-4956-B39F-DB545E11C302Q47110053-6584BAB8-B781-49DB-94F7-666DA7C23B39Q47645085-EEA75CCF-3F35-420B-BAB4-1537FEE11BF2Q47703297-58B01CEE-4E9A-49AD-BC3C-3CA1098A868EQ48290805-F1DF13BB-92A6-4C8B-8524-53976475F0C0Q48939527-17FD32C3-5247-406D-B571-103E295AA881Q50553594-E38C09AD-8068-4A68-80F5-C33C7EECA400Q51739093-61C1C216-D360-40D7-82E8-5AE55E87FF5EQ53345656-05047B3A-D956-407B-99F5-C42A56E7B383Q53347045-2F56A1AC-686C-4AD2-8134-9AE623BD3931Q53447021-E9692E2B-12BF-46AC-8C6D-4EB765B8B531
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Biomarkers in brain disease. Preface.
@en
Biomarkers in brain disease. Preface.
@nl
type
label
Biomarkers in brain disease. Preface.
@en
Biomarkers in brain disease. Preface.
@nl
prefLabel
Biomarkers in brain disease. Preface.
@en
Biomarkers in brain disease. Preface.
@nl
P1476
Biomarkers in brain disease. Preface.
@en
P356
10.1111/J.1749-6632.2009.05064.X
P577
2009-10-01T00:00:00Z